NCT01015703View on ClinicalTrials.gov

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Vaccine
Interventions
BIOLOGICAL

CoVaccine HT

intramuscular injection, dose escalation

Trial Locations (1)

SE1 1YR

Quintiles Drug Research Unit, London

Sponsors
All Listed Sponsors
lead

BTG International Inc.

OTHER